Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 2 - What They Never Told You

Scientists dismayed as UK ministers clear way for gene editing of crops - but not animals

Advocates urge government to allow ‘precision breeding’ to combat disease, but RSPCA warns of ethical dangers

The Guardian - UK

A Novel Discovery Hints At Why We Stop Producing New Brain Cells — And What We Can Do About It

A new study from Stanford Medicine shows how a gene editing tool identified a gene to knock out that could promote activation of neural stem cells.

Inverse

A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-Up

A geneticist recently discovered the gene that accounts for prickliness across a variety of plants, including roses.

Inverse

From analysis to the latest developments in health,
read the most diverse news in one place.

Plants get a GMO glow-up: Genetically modified varieties are coming out of the lab and into homes and gardens

As any avid gardener will tell you, plants with sharp thorns and prickles can leave you looking like you’ve had a run-in with an angry cat. Wouldn’t it be nice to rid plants of their prickles entirely but keep the tasty fruits and beautiful flowers?

The Conversation

Designer Babies Are Here — So Why Aren't We Talking About It?

The societal implications of this technology are still vast. And researchers can already start exploring the ethics by engaging communities well ahead of time.

Inverse

Editing fetal genomes is on the horizon

Why ethical discussions with the target communities should happen sooner rather than later

Salon

Editing fetal genomes is on the horizon − a medical anthropologist explains why ethical discussions with the target communities should happen sooner rather than later

With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and funding pressures make real-time ethics oversight difficult.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading.

StockNews.com

Genetic Enhancement Key To Future Of Space Travel, Experts Say

Explore the potential of genetic enhancements in humans for space travel and the ethical considerations surrounding gene editing technology.

Top News

TB: gene editing could add new power to a 100-year-old vaccine

Tuberculosis dates back more than 9,000 years. It is the most infectious bacterial disease and in 2022 10.6 million people fell ill with it. Of these 23% occurred in Africa.

The Conversation

Gene editing's next big targets

Scientists are pursuing advances to address the technology's limitations and stretch gene editing to treat different types of diseases, improve agriculture, livestock and more.

Axios

AI plus gene editing promises to shift biotech into high gear

During her chemistry Nobel Prize lecture in 2018, Frances Arnold said, “Today we can for all practical purposes read, write and edit any sequence of DNA, but we cannot compose it.” That isn’t true anymore.

The Conversation

3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling.

Barchart

3 Biotech Stocks to Consider Buying Right Away

The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Gene-editing crops to be colourful could aid weeding, say scientists

Creating visually distinctive plants likely to become important as more weed-like crops are grown for food

The Guardian - AU

Scientist who gene-edited babies is back in lab and ‘proud’ of past work despite jailing

China’s He Jiankui, who used Crispr to edit genome, says he is working on genetic diseases and suggests human embryo gene editing will one day be accepted

Top News

Exploring The Top 10 Genetic Engineering Breakthroughs

Explore the latest breakthroughs in genetic engineering, from CRISPR-Cas9 to gene therapy, and their impact on healthcare and conservation.

Top News

Exploring The Top 10 Genomic Medicine Breakthroughs

Explore how genomic innovations are revolutionizing healthcare with precision gene editing and personalized treatments.

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Advancements in AI, virtual reality, and gene editing will reshape society

Explore the biggest technology trends that are expected to shape our lives in the next 10 years, from AI integration and virtual reality to genetic enginee...

WEKU

New gene-editing tools may help wipe out mosquito-borne diseases

Scientists say gene-editing technology may eradicate a mosquito in the U.S. that spreads dengue and other diseases. Concerns remain about the possible environmental impact of bioengineered mosquitoes.

Top News

Medical Breakthroughs Revolutionize Health Care in 2024 and Beyond!

Discover the incredible advancements in healthcare for 2024: from groundbreaking vaccines to animal organ transplants, gene editing, and more. Exciting tim...

International Business Times

CRISPR QC: Transforming Agriculture Through Gene Editing Innovation

CRISPR QC provides clarity and insights into gene editing by quantifying risks, ensuring consistency and offering real-time data interpretation through their analytics platform.

The Hindu

US approves two gene therapies for sickle cell disease

The U.S. Food and Drug Administration on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.

Inverse

The First CRISPR Gene Therapy Was Finally Approved In The US — Here’s How It Works

Using the gene editing tool CRISPR, the new therapy promises a cure for those with sickle cell anemia and beta thalassemia, but cost could be a barrier to care.

The Independent UK

UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia

Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the…

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Harvard Medical School

131 stories

Medical Pharmaceuticals

Vertex Pharmaceuticals Incorporated

65 stories

Eli Lilly and Company

60 stories

Vertex Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.